Two Sigma Securities, LLC Cybin Inc. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.41 - $0.88 $7,495 - $16,087
-18,281 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.74 - $1.22 $193 - $319
-262 Reduced 1.41%
18,281 $15,000
Q4 2021

Feb 14, 2022
BUY
$1.13 - $2.31 $9,601 - $19,628
8,497 Added 84.58%
18,543 $22,000
Q3 2021

Nov 15, 2021
BUY
$1.83 - $3.18 $18,384 - $31,946
10,046 New
10,046 $22,000

Others Institutions Holding CYBN

# of Institutions
8
Shares Held
66.1K
Call Options Held
0
Put Options Held
0
View Full List

About CYBIN INC.

CYBN Quotes by TradingView
  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.58B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email